Navigation Links
ACRES Names Katherine Madigan VP for Global Alliances and Advocacy
Date:11/30/2013

(PRWEB) November 30, 2013

ACRES, the Alliance for Clinical Research Excellence and Safety, a collaborative non-profit organization building a global system for clinical research, has named Katherine Madigan, MHSA, as its new Vice-President for Global Alliances and Advocacy.

Ms. Madigan brings in-depth knowledge of the clinical research enterprise and organizational development to ACRES. She previously led the Association of Clinical Research Organizations (ACRO) as Senior Vice President, where she directed the business operations and international lobbying activities on behalf of the global clinical outsourcing industry.

Prior to ACRO, she served as Director of Government Affairs & Special Projects at the Association of Clinical Research Professionals (ACRP), an ACRES strategic ally, founding the organization’s government affairs practice and focusing on international coalition building. Madigan concurrently served as Managing Director of the Academy of Physicians in Clinical Research, an ACRP affiliate, responsible for governance and strategic development for the physician-only organization. Her experience also includes public policy analysis and development in the office of Robert Merrifield, member of the Canadian Parliament, where she developed drug safety initiatives for Health Canada, and in 2001 she studied public opinion of stem cell research within the Office of the Agency Liaison at The White House under President George W. Bush.

“We are thrilled to have Ms. Madigan join the ACRES leadership team”, said Dr. Greg Koski, ACRES President and CEO. “An individual with the unique range of experiences in public policy, regulatory affairs, organizational management, networking and communications across the entire world of clinical research is simply invaluable—she knows how to build meaningful relationships, and we intend to put her knowledge and skills to work immediately”, he added.

In her new roll, Madigan will assume overall responsibility for building and managing the ACRES Alliance, a global collaborative of like-minded organizations, sponsors, CROs, service providers and advocacy groups committed to promoting safety, quality, efficiency and integrity in clinical research. ACRES has already established several strategic relationships with organizations that share a commitment to creating and implementing integrated systems solutions for the global clinical research enterprise that benefit all stakeholders.

In addition to her roll at ACRES, Madigan is a Principal of Madigan Partners, a professional services firm serving the life sciences and defense industries. She provides international development, advocacy and public affairs representation for clients, with focus in North America, the European Union/EEA and Asia. Her fields of specialty include healthcare, drug and device development, clinical trials, data privacy/protection, and security. Ms. Madigan graduated with a Bachelor of Arts in political science from the University of Michigan, where she also received a Masters in Health Services Administration and Public Health. She is an active member of the Junior League of Washington D.C. and the American Association of Medical Society Executives, most recently holding leadership positions as Public Relations Chair and Member of the Leadership Academy Board.

Read the full story at http://www.prweb.com/releases/GregKoskiACRES/MadiganVP/prweb11380735.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinical Research Site-Expert Johan Karlberg to Lead ACRES Global Network Development
2. ACRES and PharmaTrain Announce Strategic Alliance
3. ACRES Announces Strategic Alliance with Atlantis Global Research Institute
4. ACRES Launches Global Clinical Research Network Technology Platform
5. ISPE Names Dr. Thomas Zimmer as Vice President of European Operations
6. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
7. Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
8. Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting
9. Genera Energy Names Sam Jackson VP of Business Development
10. Adheron Therapeutics Names New Senior Leadership
11. Golden West Biologicals Names Matriks as Distribution Partner in Norway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017 Dr. Chris Yu ... corporation Anpac Bio-Medical Science Company , announced ... record, processing and reporting over 40,000 cases worldwide ... (CDA) liquid biopsy tests. Described ... Summit publications, Anpac Bio,s CDA medical devices and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for Parkinson’s ... study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation ... produce more neural cells. , Strategies involving transplantation of these cells into ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. (NASDAQ: ... solutions for the detection of foodborne pathogens,  today announced that ... & Company Spring 2017 Convention on March 29 at 9:50am ... Marriott Marquis. About Roka Bioscience ... Roka Bioscience ...
Breaking Biology Technology:
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):